Search Results 6951-6960 of 42599 for oral

  1. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  3. Vaping unknowns: Mayo Clinic expert answers questions about vaping

    And they are what the Food and Drug Administration deems as generally recognized as safe, oe GRAS generally recognized as safe for oral ingestion — not for ...

  4. Mouth cancer - Doctors and departments - Mayo Clinic

    Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...

  5. Tobramycin and dexamethasone (ophthalmic route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Suspension; Ointment. Back to top ...

  6. T Cell Lymphoma Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...

  7. Study Of AMG 650 In Adult Participants With Advanced Solid Tumors - Mayo Clinic

    Gastrointestinal (GI) tract disease causing the inability to take oral medication. Participating Mayo Clinic locations. Study statuses change often. Please ...

  8. A Registry for Cirrhosis that has a Sustained Virologic Response Following Sofosbuvir-Based Treatment without Interferon, for Patients who have Chronic Hepatitis C Infection - Mayo Clinic

    An all-oral SOF-based regimen (outside a clinical study). Must have documentation of the regimen, start and end of treatment dates (month and year), and of ...

  9. PF-04449913 Single-Agent In Patients with Myelofibrosis Previously Treated with a Janus Kinase Inhibitor - Mayo Clinic

    Following the lead-in, a phase 2, randomized, double blind, 2 arm study of oral single agent PF 04449913 versus placebo will be tested in patients resistant ...

  10. Hemodynamic Effects Of A Novel Myeloperoxidase Inhibitor With Exercise In Heart Failure With Preserved Ejection Fraction - Mayo Clinic

    The purpose of this study is to determine the effect of a single dose of an oral acute MPO inhibitor drug on resting and exercise hemodynamics (arterial ...